TrialCancer science2025

Nelarabine-combined chemotherapy improves outcome of T-cell acute lymphoblastic leukemia but shows more severe neurotoxicity: JALSG T-ALL213-O.

Fumihiko Hayakawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.